ATROPINE SULFATE .4 mg/mL (Atropine Sulfate INJECTION, SOLUTION) .4 mg/mL

Atropine Sulfate 0.4 mg/mL is an injectable solution used for various medical purposes. This single-dose vial is manufactured by Accord Healthcare Inc. in the USA.

Strength

.4 mg/mL

Pack Size

25 VIAL, SINGLE-DOSE in 1 CARTON (16729-525-08) / 1 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Accord Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Atropine Sulfate is commonly used to treat certain types of bradycardia, or slow heart rate, and to reduce saliva, mucus, and other secretions in the airways. It may also be used during surgical procedures to block certain nerve impulses. People often ask, 'What is Atropine Sulfate used for?' and the answer includes its role in managing specific heart conditions and reducing secretions.

Side Effects

Atropine Sulfate can cause effects such as dry mouth, blurred vision, and increased heart rate. Some individuals may experience dizziness or difficulty urinating. These effects can vary depending on the individual and the specific use case.

Precautions & Warnings

Atropine Sulfate should be handled with care, as it is a potent medication. It is important to follow proper administration guidelines and to store it according to the manufacturer's instructions. Always consult a healthcare provider before use.

Avoid Interactions

Atropine Sulfate may interact with other medications, including those that affect the central nervous system or have anticholinergic properties. It is also important to be cautious when combining it with alcohol or other substances that can cause drowsiness.

Frequently Asked Questions

Atropine Sulfate is used to treat certain types of bradycardia and to reduce secretions in the airways. It may also be used during surgical procedures.

Atropine Sulfate is administered intravenously as an injectable solution. It is available in single-dose vials.

Common side effects include dry mouth, blurred vision, increased heart rate, dizziness, and difficulty urinating.

Atropine Sulfate may interact with other medications, especially those that affect the central nervous system or have anticholinergic properties.

Atropine Sulfate should be stored according to the manufacturer's instructions, typically in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.